Global News

[ad_1] There's a global investing opportunity in a corner of health care that is both "significant and underappreciated," according to Barclays. The segment is clinical nutrition, which the bank defined as an area focused on patients who need specific supplemental nutrition because of chronic health care conditions or because they are unable to eat. Barclays pointed to several growth drivers: "Rising chronic conditions, ageing populations and continued pressure on healthcare spending should continue to support the growth of this industry." "Clinical nutrition provides supplemental nutrition for those who are malnourished and is a significant and underappreciated opportunity worth c.$19bn today, driven by strong underlying themes such as ageing population, malnutrition and an increasing focus on self-care," the bank said in an April 12 note. It expects the market will grow to $28 billion by 2030, with China's share of the market rising from 20%

[ad_1] Fanatics founder and CEO Michael Rubin at his office in New York. The Washington Post | Getty Images Fanatics held its second investor day in nearly a year as the company quietly moves closer to an initial public offering, a source familiar with the matter tells CNBC. More than 100 existing and prospective institutional investors from major firms such as Goldman Sachs and Barclays gathered Tuesday for the meeting at the NBA Players Association headquarters in New York to hear from Fanatics founder and CEO Michael Rubin, the source said. Another 300 people attended the meeting virtually on Zoom. Leaders from all parts of the business gave presentations and took part in a Q&A session with the audience. A spokesman for Fanatics said the company's timeline for an IPO hasn't changed. Investors were also treated to a surprise visit by football great Tom Brady, an investor in the company. Brady spoke to investors about business and leadership and mingled with the aud